Back to Treatments

Treatment

Tofacitinib

3
Conditions
182
Trials
36K
Participants
47%
Average Safety

Condition Evidence

Inflammatory bowel disease

40 trials · 8,000 participants

72% effectiveness · 48% safety

Rheumatoid arthritis

105 trials · 25K participants

78% effectiveness · 38% safety

Ulcerative Colitis

37 trials · 3,000 participants

75% effectiveness · 55% safety
Tofacitinib | DFDA